Recent hospitalization is the strongest risk factor for VTE in HIV-infected patients.
Multiple studies have suggested that HIV-infected patients are at increased risk for venous thromboembolism (VTE), perhaps because of comorbidities or hypercoagulability. To determine which HIV-infected patients are at highest risk for VTE, investigators conducted a case-control study using data from the Johns Hopkins University AIDS Service cohort.
The researchers identified 160 cases of VTE in the cohort, yielding an incidence of 0.54% per patient-year. The most common events were deep venous thromboses (DVTs; 109 events) and pulmonary emboli (39 events). Thirty percent of DVTs were in the upper extremity. The strongest risk factor for VTE was hospitalization during the preceding 3 months (adjusted odds ratio, 13.0; 95% confidence interval…
Reviewing Author
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)